These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26478662)

  • 1. Advanced pancreatic cancer - how to choose an adequate treatment option.
    Korkeila EA
    World J Gastroenterol; 2015 Oct; 21(38):10709-13. PubMed ID: 26478662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Approaches for Metastatic Pancreatic Adenocarcinoma.
    Rubinson DA; Wolpin BM
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):761-76. PubMed ID: 26226909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current standards and new innovative approaches for treatment of pancreatic cancer.
    Conroy T; Bachet JB; Ayav A; Huguet F; Lambert A; Caramella C; Maréchal R; Van Laethem JL; Ducreux M
    Eur J Cancer; 2016 Apr; 57():10-22. PubMed ID: 26851397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets.
    Sclafani F; Iyer R; Cunningham D; Starling N
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):318-36. PubMed ID: 25921418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adenocarcinoma of the pancreas. Therapeutic strategies].
    André T; Balosso J; Louvet C; Houry S; Vaillant JC; Touboul E; Lotz JP; de Gramont A; Izrael V
    Presse Med; 1998 Mar; 27(11):539-45. PubMed ID: 9767970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative care from the beginning of treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Lazenby JM; Saif MW
    JOP; 2010 Mar; 11(2):154-7. PubMed ID: 20208326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic ductal adenocarcinoma: metastatic disease.
    Muñoz Martín AJ; Adeva J; Martínez-Galán J; Reina JJ; Hidalgo M
    Clin Transl Oncol; 2017 Dec; 19(12):1423-1429. PubMed ID: 28623515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancements in the management of pancreatic cancer: 2013.
    Saif MW
    JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status in chemotherapy for advanced pancreatic adenocarcinoma.
    Cao H; LE D; Yang LX
    Anticancer Res; 2013 May; 33(5):1785-91. PubMed ID: 23645722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic pancreatic cancer: the dilemma of quality vs. quantity of life.
    Shahrokni A; Saif MW
    JOP; 2013 Jul; 14(4):391-4. PubMed ID: 23846935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined-modality treatment for operable pancreatic adenocarcinoma.
    Pisters PW; Wolff RA; Crane CH; Evans DB
    Oncology (Williston Park); 2005 Mar; 19(3):393-404, 409; discussion 409-10, 412-6. PubMed ID: 15828554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy and other supportive modalities in the palliative setting for pancreatic cancer.
    Sullivan KM; Kozuch PS
    Cancer J; 2012; 18(6):633-41. PubMed ID: 23187852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative Serum Albumin Level is a Marker of Incomplete Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma.
    Matsumoto I; Tanaka M; Shirakawa S; Shinzeki M; Toyama H; Asari S; Goto T; Yamashita H; Ishida J; Ajiki T; Fukumoto T; Shimokawa M; Ku Y
    Ann Surg Oncol; 2015 Jul; 22(7):2408-15. PubMed ID: 25487967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The case for routine use of adjuvant therapy in pancreatic cancer.
    Kennedy EP; Yeo CJ
    J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current diagnosis and treatment of pancreatic cancer].
    Heinrich S; Schäfer M; Bauerfeind P; Pestalozzi BC; Clavien PA
    Praxis (Bern 1994); 2005 Aug; 94(33):1243-54. PubMed ID: 16138769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non surgical treatment of pancreatic cancers].
    Bleiberg H; Gerard B; Hendlisz A; Jagodzinski R
    J Chir (Paris); 1997 Sep; 134(4):169-73. PubMed ID: 9499945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives in chemotherapy of pancreatic cancer.
    Klapdor R
    Eur J Surg Oncol; 1991 Apr; 17(2):153-66. PubMed ID: 1707835
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combination therapy with lentinan, mitomycin c, 5-fluorouracil and radiation--a case of long-term survival of pancreas cancer after palliative surgery].
    Kunitomo K; Kawahito M; Miura M; Komi N
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1342-4. PubMed ID: 2437863
    [No Abstract]   [Full Text] [Related]  

  • 20. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.